Skip to main content

Table 2 Primary and secondary endpoints of the study

From: Antimicrobial stewardship measures in cardiac surgery and its impact on surgical site infections

Endpoints of the study Total Cefuroxime Cefazolin p
SSI total (%) 37 (3.6) 20 (3.4) 17 (3.8) 0.754
DSWI (%) 18 (1.7) 12 (2.1) 6 (1.3) 0.383
Vein harvesting site (%) 17 (1.7) 7 (1.2) 10 (2.2) 0.197
Urinary tract infections (%) 40 (4.0) 26 (4.6) 14 (3.3) 0.306
Pneumonia/trachebronchitis (%) 70 (7.0) 41 (7.1) 29 (6.7) 0.818
Sepsis (%) 11 (1.1) 8 (1.4) 3 (0.7) 0.294
Death (%) 40 (3.9) 19 (3.3) 21 (4.7) 0.238